| Year |
Citation |
Score |
| 2023 |
Sridharan D, Pracha N, Rana SJ, Ahmed S, Dewani AJ, Alvi SB, Mergaye M, Ahmed U, Khan M. Preclinical Large Animal Porcine Models for Cardiac Regeneration and Its Clinical Translation: Role of hiPSC-Derived Cardiomyocytes. Cells. 12. PMID 37048163 DOI: 10.3390/cells12071090 |
0.3 |
|
| 2022 |
Ponnalagu D, Hamilton S, Sanghvi S, Antelo D, Schwieterman N, Hansra I, Xu X, Gao E, Edwards JC, Bansal SS, Wold LE, Terentyev D, Janssen PML, Hund TJ, Khan M, et al. CLIC4 localizes to mitochondrial-associated membranes and mediates cardioprotection. Science Advances. 8: eabo1244. PMID 36269835 DOI: 10.1126/sciadv.abo1244 |
0.338 |
|
| 2022 |
Sanghvi S, Szteyn K, Ponnalagu D, Sridharan D, Lam A, Hansra I, Chaudhury A, Majumdar U, Kohut AR, Gururaja Rao S, Khan M, Garg V, Singh H. Inhibition of BK channels protects neonatal hearts against myocardial ischemia and reperfusion injury. Cell Death Discovery. 8: 175. PMID 35393410 DOI: 10.1038/s41420-022-00980-z |
0.315 |
|
| 2020 |
Dougherty JA, Patel N, Kumar N, Rao SG, Angelos MG, Singh H, Cai C, Khan M. Human Cardiac Progenitor Cells Enhance Exosome Release and Promote Angiogenesis Under Physoxia. Frontiers in Cell and Developmental Biology. 8: 130. PMID 32211408 DOI: 10.3389/Fcell.2020.00130 |
0.399 |
|
| 2019 |
Ponnalagu D, Hussain AT, Thanawala R, Meka J, Bednarczyk P, Feng Y, Szewczyk A, GururajaRao S, Bopassa JC, Khan M, Singh H. Chloride channel blocker IAA-94 increases myocardial infarction by reducing calcium retention capacity of the cardiac mitochondria. Life Sciences. 116841. PMID 31494173 DOI: 10.1016/J.Lfs.2019.116841 |
0.447 |
|
| 2018 |
Goswami SK, Ponnalagu D, Hussain AT, Shah K, Karekar P, Gururaja Rao S, Meredith AL, Khan M, Singh H. Expression and Activation of BK Channels in Mice Protects Against Ischemia-Reperfusion Injury of Isolated Hearts by Modulating Mitochondrial Function. Frontiers in Cardiovascular Medicine. 5: 194. PMID 30746365 DOI: 10.3389/Fcvm.2018.00194 |
0.444 |
|
| 2017 |
Dougherty JA, Mergaye M, Kumar N, Chen CA, Angelos MG, Khan M. Potential Role of Exosomes in Mending a Broken Heart: Nanoshuttles Propelling Future Clinical Therapeutics Forward. Stem Cells International. 2017: 5785436. PMID 29163642 DOI: 10.1155/2017/5785436 |
0.311 |
|
| 2013 |
Elnakish MT, Kuppusamy P, Khan M. Stem cell transplantation as a therapy for cardiac fibrosis. The Journal of Pathology. 229: 347-54. PMID 23011894 DOI: 10.1002/path.4111 |
0.308 |
|
| 2012 |
Hassan F, Meduru S, Taguchi K, Kuppusamy ML, Mostafa M, Kuppusamy P, Khan M. Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression. The Journal of Pharmacology and Experimental Therapeutics. 343: 62-71. PMID 22739507 DOI: 10.1124/jpet.112.196915 |
0.336 |
|
| 2011 |
Elnakish MT, Awad MM, Hassona MD, Alhaj MA, Kulkarni A, Citro LA, Sayyid M, Abouelnaga ZA, El-Sayed O, Kuppusamy P, Moldovan L, Khan M, Hassanain HH. Cardiac remodeling caused by transgenic overexpression of a corn Rac gene. American Journal of Physiology. Heart and Circulatory Physiology. 301: H868-80. PMID 21622832 DOI: 10.1152/Ajpheart.00807.2010 |
0.306 |
|
| 2009 |
Wisel S, Khan M, Kuppusamy ML, Mohan IK, Chacko SM, Rivera BK, Sun BC, Hideg K, Kuppusamy P. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. The Journal of Pharmacology and Experimental Therapeutics. 329: 543-50. PMID 19218529 DOI: 10.1124/Jpet.109.150839 |
0.309 |
|
| 2009 |
Mohan IK, Khan M, Wisel S, Selvendiran K, Sridhar A, Carnes CA, Bognar B, Kálai T, Hideg K, Kuppusamy P. Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology. 296: H140-51. PMID 18978191 DOI: 10.1152/ajpheart.00687.2008 |
0.311 |
|
| 2007 |
Khan M, Mohan IK, Kutala VK, Kumbala D, Kuppusamy P. Cardioprotection by sulfaphenazole, a cytochrome p450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species. The Journal of Pharmacology and Experimental Therapeutics. 323: 813-21. PMID 17873104 DOI: 10.1124/jpet.107.129486 |
0.307 |
|
| 2007 |
Khan M, Kutala VK, Vikram DS, Wisel S, Chacko SM, Kuppusamy ML, Mohan IK, Zweier JL, Kwiatkowski P, Kuppusamy P. Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. American Journal of Physiology. Heart and Circulatory Physiology. 293: H2129-39. PMID 17660391 DOI: 10.1152/Ajpheart.00677.2007 |
0.304 |
|
| 2007 |
Kutala VK, Khan M, Angelos MG, Kuppusamy P. Role of oxygen in postischemic myocardial injury. Antioxidants & Redox Signaling. 9: 1193-206. PMID 17571958 DOI: 10.1089/Ars.2007.1636 |
0.32 |
|
| 2006 |
Kutala VK, Khan M, Mandal R, Potaraju V, Colantuono G, Kumbala D, Kuppusamy P. Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol. Journal of Cardiovascular Pharmacology. 48: 79-87. PMID 17031260 DOI: 10.1097/01.fjc.0000242050.16790.65 |
0.322 |
|
| 2006 |
Kutala VK, Khan M, Mandal R, Ganesan LP, Tridandapani S, Kalai T, Hideg K, Kuppusamy P. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. The Journal of Pharmacology and Experimental Therapeutics. 317: 921-8. PMID 16467453 DOI: 10.1124/Jpet.105.100834 |
0.326 |
|
| 2006 |
Khan M, Varadharaj S, Ganesan LP, Shobha JC, Naidu MU, Parinandi NL, Tridandapani S, Kutala VK, Kuppusamy P. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2136-45. PMID 16373583 DOI: 10.1152/Ajpheart.01072.2005 |
0.313 |
|
| Show low-probability matches. |